Drugs / ASA
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT00853450 Background | Feb → Jul 2009 | — | AstraZeneca | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ASA | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00853450 ↗ |
| Route | Oral | “75 mg orally once daily during 7 days in each treatment arm” NCT00853450 ↗ |